Summit Therapeutics (SMMT.MX) Q3 2024 Earnings

6AugConfirmed
Q3 2024
-1.21
-1.13
-1.06
-0.98

Details

Expected EPS
-1.2106201627800002
Actual EPS
-0.9784845000000001
Surprise EPS
0.23
Surprise Percent
+19.17%

Description

Summit Therapeutics (SMMT.MX) has reported earnings of -0.9784845000000001 per share for Q3 2024.

0 Comments

Share your thoughts